The war on the medical care of senior Americans continues.
Diabetes patients on Medicare Part D are two to three times more likely to be prescribed brand-name drugs than comparable patients receiving care within the U.S. Department of Veterans Affairs (VA), at an added cost of about $1 billion a year.
Medicare and the VA have a significantly different approach to drug prescribing. Medicare contracts with more than 1,000 private insurance companies, each using a distinct formulary and cost-sharing arrangement for prescribing drugs.